The SLC15A4-TASL complex is essential for lupus development in mice.

Authors

Ales Drobek, Maeva Delacrétaz, Aliki Vasilakou, Marta Monguió-Tortajada, Léa Bernaleau, Maxime Dubois, Vanja Sisirak, Manuele Rebsamen

Published in

Proceedings of the National Academy of Sciences of the United States of America. Volume 123. Issue 36. Pages e2618215123. Sep 08, 2026. Epub Sep 01, 2026.

Abstract

Nucleic acid sensing by endolysosomal Toll-like receptors is critically involved in systemic lupus erythematosus (SLE) and related autoimmune diseases. Downstream of TLR7, TLR8, and TLR9, the SLE-associated SLC15A4-TASL complex selectively mediates IRF5 activation, while being dispensable for NF-κB and MAPK pathways. Here, we show that the SLC15A4-TASL signaling axis is broadly required for disease development and pathogenesis across three complementary genetic SLE models, reflecting different etiologies. Genetic ablation of Tasl (Tasl^KO) and its paralogue Tasl2 (Tasl^DKO) ameliorated or fully prevented autoimmune manifestations resulting from Fas^lpr loss of function, respectively. Furthermore, SLC15A4-TASL complex deficiency was sufficient to protect from disease, including splenomegaly, immune activation, and autoantibody formation, driven by the patient-derived Tlr7^Y264H gain-of-function mutation, even in the presence of functional NF-κB and MAPK responses. Last, Tasl^DKO splenocyte transfer into lymphopenic Dnase1l3-deficient mice demonstrated that protection extends to DNA-driven autoimmunity, in which TLR7 and TLR9 act redundantly, strongly supporting a B cell-intrinsic role. Notably, SLC15A4-TASL complex deficiency blunted the generation of pathogenic age-associated B cells in all three autoimmune models as well as in aged animals. Collectively, these data demonstrate the central role of the SLC15A4-TASL complex in SLE, supporting its potential as therapeutic target.

PMID:
42679023
Bibliographic data and abstract were imported from PubMed on 02 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.